title: HOXA-activated early T-cell progenitor acute lymphoblastic leukemia: predictor of poor outcome?
authors.affiliation: Department of Pediatric Oncology/Hematology, Sophia Children's Hospital, Rotterdam, the Netherlands j.meijerink@erasmusmc.nl.
authors.forename: Jules Pp
authors.initials: JP
authors.lastname: Meijerink
authors.affiliation: Department of Pediatric Oncology/Hematology, Sophia Children's Hospital, Rotterdam, the Netherlands.
authors.forename: Kirsten
authors.initials: K
authors.lastname: Canté-Barrett
authors.affiliation: Department of Pediatric Oncology/Hematology, Sophia Children's Hospital, Rotterdam, the Netherlands.
authors.forename: Eric
authors.initials: E
authors.lastname: Vroegindeweij
authors.affiliation: The Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
authors.forename: Rob
authors.initials: R
authors.lastname: Pieters
mesh_terms: D018572:Disease-Free Survival; D018398:Homeodomain Proteins / Q000235:genetics / Q000378:metabolism; D006801:Humans; D009363:Neoplasm Proteins / Q000235:genetics / Q000378:metabolism; D054218:Precursor T-Cell Lymphoblastic Leukemia-Lymphoma / Q000235:genetics / Q000378:metabolism / Q000401:mortality; D015996:Survival Rate
chemical_list: D018398:Homeodomain Proteins; D009363:Neoplasm Proteins; C088144:HoxA protein